# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-056966
Filing Date
2025-04-23
Accepted
2025-04-23 07:33:44
Documents
39
Period of Report
2025-04-23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | apls-20250421.htm iXBRL | DEF 14A | 2304475
2 | GRAPHIC | img139998651_0.jpg | GRAPHIC | 27776
3 | GRAPHIC | img139998651_1.jpg | GRAPHIC | 2500
4 | GRAPHIC | img139998651_2.jpg | GRAPHIC | 3799
5 | GRAPHIC | img139998651_3.jpg | GRAPHIC | 2353
6 | GRAPHIC | img139998651_4.jpg | GRAPHIC | 3285
7 | GRAPHIC | img139998651_5.jpg | GRAPHIC | 13059
8 | GRAPHIC | img139998651_6.jpg | GRAPHIC | 15051
9 | GRAPHIC | img139998651_7.jpg | GRAPHIC | 11761
10 | GRAPHIC | img139998651_8.jpg | GRAPHIC | 14409
11 | GRAPHIC | img139998651_9.jpg | GRAPHIC | 14167
12 | GRAPHIC | img139998651_10.jpg | GRAPHIC | 16338
13 | GRAPHIC | img139998651_11.jpg | GRAPHIC | 12706
14 | GRAPHIC | img139998651_12.jpg | GRAPHIC | 40290
15 | GRAPHIC | img139998651_13.jpg | GRAPHIC | 44664
16 | GRAPHIC | img139998651_14.jpg | GRAPHIC | 20348
17 | GRAPHIC | img139998651_15.jpg | GRAPHIC | 53524
18 | GRAPHIC | img139998651_16.jpg | GRAPHIC | 10241
19 | GRAPHIC | img139998651_17.jpg | GRAPHIC | 8619
20 | GRAPHIC | img139998651_18.jpg | GRAPHIC | 7993
21 | GRAPHIC | img139998651_19.jpg | GRAPHIC | 10201
22 | GRAPHIC | img139998651_20.jpg | GRAPHIC | 50497
23 | GRAPHIC | img139998651_21.jpg | GRAPHIC | 50501
24 | GRAPHIC | img139998651_22.jpg | GRAPHIC | 50888
25 | GRAPHIC | img139998651_23.jpg | GRAPHIC | 41751
26 | GRAPHIC | img139998651_24.jpg | GRAPHIC | 1355367
27 | GRAPHIC | img139998651_25.jpg | GRAPHIC | 232512
| Complete submission text file | 0000950170-25-056966.txt |  | 8698158

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
28 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | apls-20250421.xsd | EX-101.SCH | 54146
41 | EXTRACTED XBRL INSTANCE DOCUMENT | apls-20250421_htm.xml | XML | 564112

Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38276 | Film No.: 25859217
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)